Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways
Alexander Akhmedov(University of Zurich), Thomas F. Lüscher(University of Zurich), Simona Stivala(University of Basel), Ariane Schaub Clerigué(University of Zurich), Thimoteus Speer(Goethe University Frankfurt), Remo D. Spescha(University of Zurich), Sarah Costantino(Sapienza University of Rome), Alexander Breitenstein(University of Zurich), Francesco Paneni(University of Zurich), Giovanni G. Camici(University of Zurich), Martin F. Reiner(University of Zurich), Christine Lohmann(University of Zurich), Jasmin Manz(University of Zurich), Erik W. Holy(Segeberger Kliniken), Nicole R. Bonetti(University Hospital Zurich)
Cited by 36
Related Papers
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I
|European Heart Journal|2013|1.4k
The Assessment of Endothelial Function
|Circulation|2012|1.1k
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
|Journal of Clinical Investigation|1990|1.1k
Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans
|European Heart Journal|2019|952